Eric Boduch has been involved with both startup and publicly traded software companies in senior management positions since 1995. He has extensive technology marketing, product management, strategy development and business development experience. He currently is a founder and board member of Pendo.io, a venture backed software company. Pendo is a data driven platform for product engagement that enables companies to improve onboarding, understand product usage and help retain customers. Previously, he was CEO of SMaSh, a mobile SMS technology company, and was VP of Marketing for Vitria Inc., a publicly traded software vendor based in silicon valley. Before Vitria, Mr. Boduch held senior positions at Embarcadero Technologies, ProductSoft, and Cerebellum Software. He has a BS in Electrical and Computer Engineering from Carnegie Mellon University.
Phil Brooks, MBA
Phil has served as a consultant to or C-level executive (eight companies) for manufacturing, mining, information technology, entertainment and life science companies at the startup stage and global corporation level. During the course of a 30+ year business career Phil has developed critical skills, including: successful grant writing; strategic planning; effective complex project, department, and corporate management; successful marketing and sales; recruiting; training; vendor, facilities and information technology management; and evaluating, establishing and managing human resource programs. Particular expertise developed in finance, accounting, intellectual property economics, decision analysis, technical writing support for grant applications and reports, grant budget development, market research, competitive analysis, strategic partner and investor introductions, and presentation development and coaching.
Phil has also served in a variety of roles with university-based spinouts (University of Pittsburgh, Carnegie Mellon University and Lehigh University). His assistance has included: mentor (NSF I-Corps Learning Team, Coulter Foundation, 1st Gear, Science 2014/2015); grant consultant (Phase I, Phase II, i6 SBIR supplement); CEO and COO of two stem cell companies; and board member. Phil currently serves as Chairman of BlueTree Allied Angels’ Growth and Transaction Committee and a member of the Screening Committee.
In addition, Phil is a co-owner of Brooks Consulting LLC, a 17-year old management-consulting firm. Brooks Consulting is a Preferred Provider in Pennsylvania’s Innovation Partnership assisting clients who are awarded MicroGrant, MicroVoucher or Federal Marketing Assistance funding. Prior to starting this business, Phil owned a PR firm focused on the high tech sector, served as a director with Big Six accounting firms in Pittsburgh, was a partner with an economic consulting firm in Washington, DC and a chemist in the pharmaceutical sector in New York. He holds a BS in Biology, an MS in Pharmacotherapeutics and an MBA and obtained a certification (expired) as an Emergency Medical Technician.
Greg Coticchia, MBA, PC
Greg is an award-winning technology executive with over twenty-five years of experience in high tech products and services. He has led or been a major contributor in two of the largest and most successful software companies in the world, LEGENT (now CA) and AXENT (now Symantec). Greg has been in fourteen start-ups, founding four, and has held executive positions for better than two-thirds of his career, participating in various size organizations, from $0M to over $1B in revenue. A graduate of the University of Pittsburgh in Industrial Engineering, where he also received his MBA, he currently teaches several courses including B2B marketing at the University Of Pittsburgh Katz School Of Business. He holds certificates in Entrepreneurial Management from Carnegie Mellon University and Professional Coaching from Duquesne University. Greg was named as a finalist three times for the Ernst and Young Entrepreneur of the Year Award and for the Tech 50 CEO of the Year. He was also named a 2006 Distinguished Graduate of the University of Pittsburgh (Katz).
Mara J. Horwitz, MD
Mara is a Board-certified endocrinologist who received her BA from Northwestern University and her MD from Columbia University, College of Physicians and Surgeons. She completed both her internal medicine residency and a research-based endocrine fellowship at the University of Pittsburgh. Since completing her training, Dr. Horwitz has held academic positions as a clinician and clinical researcher at Columbia University, SUNY Stonybrook and the University of Minnesota. She is currently an Associate Professor of Medicine at the University of Pittsburgh where the majority of her career has focused on NIH funded clinical research in metabolic bone disease. She has also participated in numerous pharmaceutical sponsored clinical trials and currently holds two IND’s. In addition, Mara has been a long-standing member of the University of Pittsburgh Conflict of Interest Committee and she serves as the Medical Monitor for the Education and Compliance Office for Human Subject Research.
Michael brings more than 20 years of experience in clinical research, drug and medical device development across a wide range of therapeutic areas. He is the Vice President for Regulatory Affairs, Behavioral Science, and Innovation at Pinney Associates, a pharmaceutical consulting firm.
Michael’s drug development experience includes serving as Cypress Bioscience’s Vice President of Corporate and Clinical Development, where he had responsibility for development of the drug and medical device portfolio for multiple CNS assets, including the FDA approval of Savella (milnacipran) for fibromyalgia. Before joining Cypress, he worked at Amylin Pharmaceuticals, leading drug development teams focused on orphan drug development for rare metabolic diseases, and combination peptide and protein therapies for obesity. Michael also served as Vice President of Scientific Affairs at invivodata, where he was responsible for scientific consulting on patient-reported outcome claim construction for more than 50 drug development programs. An entrepreneur, Michael has co-founded and raised venture and angel capital for multiple pharmaceutical, device, and mobile health companies including NQ Oncology, e-Nicotine Technology, and MindApps.
Michael is a graduate of Purdue University. He earned his master’s and doctoral degrees in Clinical Psychology from the University of Pittsburgh before completing a Research and Clinical Fellowship in the Department of Psychiatry at Harvard Medical School.
Joe Marcanio is a seasoned operations professional with solid start-up experience, accomplished in technology development and manufacturing. An engineer by training, his technical skills and business values were forged in high-tech, large-scale manufacturing operations serving competitive global markets. His technology background includes microcircuits, biosensors, chemical processing, and materials and he is named as inventor on over 20 patent applications. On the business side, Joe successfully pitched venture deals to senior leadership of Fortune 500 companies and raised over $50M in financing for startup projects. He has held COO and CEO roles, and was responsible for the design, construction, and operation of a plant that delivered $50M to Sony’s bottom line. He has developed strategic relationships in Europe and Asia and is one of only three industry experts invited to NSF’s 2014 workshop to develop the National Nanotechnology Coordinated infrastructure program.
Kevin Mendelsohn is a Venture Partner at JumpStart Inc., a northeast Ohio-based venture development and investment organization. Mr. Mendelsohn has approximately twenty years of experience working in investment and operational management roles for early stage medtech and biotechnology companies. Most recently, he led finance and corporate development at CardioInsight Technologies, an electrocardiographic mapping company that was acquired by Medtronic, a leading international medical device company.
John’s new venture experience as an investor, advisor, executive and board member spans healthcare IT, mobile cloud-based applications, medical device manufacturing and affective computing. His corporate career included functional leadership roles for global medical device and technology firms in corporate development, strategic planning and finance. He holds an M.B.A. from Duke University and a B.A. from the University of Pittsburgh.
Lorenzo Soletti, Ph.D., MBA
Lorenzo holds a Masters of Science degree in Biomedical Engineering (Research Focus on Blood Processing Artificial Organs), a PhD in Bioengineering from Pitt (Research Focus on Vascular Regenerative Medicine), and an MBA from CMU Tepper School of Business (Focus on Technology Strategy and Quantitative Methods). In 2009 Lorenzo co-founded Neograft Technologies, a Pitt technology-based medical device company developing a Class III implantable cardiac device, and led the R&D for the company until the end of 2014. In 2015 Lorenzo joined the Pitt Innovation Institute as Entrepreneur in Residence, where he is helping commercializing high-potential technologies and developing internal processes for optimizing deal flow. More recently in 2015 Lorenzo co-founded Venndoo, a mobile technology company developing an analytic platform to facilitate the mobilization of used goods, where is currently President and CEO.
Antonio (Tony) Torres
Tony has over 30 years of experience and has held numerous senior management positions in the Chemicals, Materials and Construction products sectors. He founded and currently operates FreeRadicals LLC, a consulting firm and investment holding company exclusively focused on sustainable building and construction methods and materials, packaging and renewable energy. Prior to FreeRadicals Tony co-founded Triventas LLC, a small-cap investment firm and was Sr. Consultant at Headwaters, a merchant banking and advisory company. These opportunities came after a long career in the chemicals industries where he worked for leading firms including Dow Chemical and Nova Chemicals. At Nova, Tony was President of its construction materials business, SYNTHEON Inc., and ran its Performance Styrenics business with accountability for over $300M in revenue. While at Dow Chemical he held numerous global assignments including; Global Business Director for Corporate New Ventures Global Growth Center, the founding of Dow Fibers Solutions, Polyolefin’s and Elastomers, as well as DOWBRANDS Consumer Products. He also oversaw the construction of an elastomeric fiber plant during this tenure.
In the last five years Tony has focused on building a global construction business through the formation of wholly-owned or joint venture companies in India, Chile, Mexico and the United States. He especially focused on the identification of critical and capable partners to successfully start-up technology based companies. Through partner companies like Reliance Industries in India and Grupo Idesa in Mexico Joint Ventures were started in record time. Mr. Torres was CEO of the India venture, Reliance Innovative Building Systems for nearly 2 years.
Tony has a Bachelor of Science in Mechanical Engineering from University of Miami, Florida. He has completed the Executive Programs at MIT for Management of Technology and the Thunderbird International Management Executive Program. Tony is fluent in Spanish and additionally is an adjunct professor for Entrepreneurship at Duquesne University.